Your browser doesn't support javascript.
loading
Improved survival with statins, angiotensin receptor blockers, and steroid weaning after heart transplantation.
Lubitz, S A; Baran, D A; Alwarshetty, M M; Zucker, M J; Arroyo, L H; Chan, M; Courtney, M C; Correa, R; Spielvogel, D; Lansman, S L; Gass, A L.
Affiliation
  • Lubitz SA; Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai Medical Center, New York, New York, USA.
Transplant Proc ; 38(5): 1501-6, 2006 Jun.
Article in En | MEDLINE | ID: mdl-16797343
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Heart Transplantation / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Angiotensin Receptor Antagonists Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 2006 Type: Article Affiliation country: United States
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Heart Transplantation / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Angiotensin Receptor Antagonists Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 2006 Type: Article Affiliation country: United States